The new fight over abortion pills

If you've optimized your free time so much that it feels like work, maybe it’s time to rethink how you craft and kayak. This episode was produced by Danielle Hewitt, edited by Avishay Artsy, fact-checked by Melissa Hirsch, engineered by David Tatasciore, and hosted by Jonquilyn H ...  Show more

Nevada is in many ways “ground zero” for this year’s midterms. The state swung to the right in 2024 and voted for Donald Trump. Now, many voters there are grappling with buyer’s remorse. This show was edited by Kasia Broussalian, fact checked by Esther Gim, mixed by Shannon Mahon ...  Show more

In 2000, the F.D.A. approved the medication abortion drug mifepristone. Now a federal judge in Texas is set to rule on a case filed by anti-abortion groups urging the agency to revoke its approval of mifepristone and the other main drug used for medication abortion in the Unit ...

Today on Post Reports, we take you to an abortion hearing in Amarillo, Tex., that the judge didn’t want you to know was coming. 

Read more:

In a four-hour hearing on Wednesday, U.S. District Judge Matthew Kacsmaryk heard arguments in

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications. Read the story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices